Anette Langebäck

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Jag jobbar som forskningskoordinator i Nikolas Herolds forskargrupp. Det övergripande målet för gruppens forskning är att hitta nya sätt för att motverka terapi-resistens vid barncancer. Min roll är att samordna olika saker som händer i gruppen och att hjälpa till med exempelvis anslagsansökningar, möten, personal- och ekonomi-ärenden.

Artiklar

Article: CELL REPORTS. 2024;43(10):114784
Proteome-wide CETSA reveals diverse apoptosisinducing mechanisms converging on an initial apoptosis effector stage at the nuclear periphery
Ramos AD; Liang YY; Surova O; Bacanu S; Gerault M-A; Mandal T; Ceder S; Langeback A; Osterroos A; Ward GA; Bergh J; Wiman KG; Lehmann S; Prabhu N; Loof S; Nordlund P
Journal article: EJC PAEDIATRIC ONCOLOGY. 2023;2:100020
Incidence and surveillance of acute cardiovascular toxicities in paediatric acute lymphoblastic leukaemia: A retrospective population-based single-centre cohort study
Alpman MS; Toth I; Langebäck A; Broberg AM; Herold N
Article: SCIENTIFIC REPORTS. 2019;9(1):19384
CETSA-based target engagement of taxanes as biomarkers for efficacy and resistance
Langeback A; Bacanu S; Laursen H; Mout L; Seki T; Erkens-Schulze S; Ramos AD; Berggren A; Cao Y; Hartman J; van Weerden W; Bergh J; Nordlund P; Loof S
Article: AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY, INTEGRATIVE AND COMPARATIVE PHYSIOLOGY. 2019;316(5):R666-R677
BRL37344 stimulates GLUT4 translocation and glucose uptake in skeletal muscle via β2-adrenoceptors without causing classical receptor desensitization.
Mukaida S; Sato M; Öberg AI; Dehvari N; Olsen JM; Kocan M; Halls ML; Merlin J; Sandström AL; Csikasz RI; Evans BA; Summers RJ; Hutchinson DS; Bengtsson T
Article: MOLECULAR METABOLISM. 2017;6(6):611-619
β₃-Adrenergically induced glucose uptake in brown adipose tissue is independent of UCP1 presence or activity: Mediation through the mTOR pathway
Olsen JM; Csikasz RI; Dehvari N; Lu L; Sandstrom A; Oberg AI; Nedergaard J; Stone-Elander S; Bengtsson T
Article: DIABETES. 2014;63(12):4115-4129
Improving type 2 diabetes through a distinct adrenergic signaling pathway involving mTORC2 that mediates glucose uptake in skeletal muscle.
Sato M; Dehvari N; Oberg AI; Dallner OS; Sandström AL; Olsen JM; Csikasz RI; Summers RJ; Hutchinson DS; Bengtsson T
Article: PLOS ONE. 2011;6(7):e22304
β-Adrenergic inhibition of contractility in L6 skeletal muscle cells.
Öberg AI; Dehvari N; Bengtsson T
Article: PLOS ONE. 2011;6(7):e22510
Shikonin Increases Glucose Uptake in Skeletal Muscle Cells and Improves Plasma Glucose Levels in Diabetic Goto-Kakizaki Rats
Oberg AI; Yassin K; Csikasz RI; Dehvari N; Shabalina IG; Hutchinson DS; Wilcke M; Ostenson C-G; Bengtsson T

Alla övriga publikationer

Conference publication: CANCER RESEARCH. 2018;78(13):5655
Biophysics in the cell-CETSA to study drug binding and cellular processes in cancer therapy
Liang YY; Ramos A; Laursen H; Surova O; Lengqvist J; Loof S; Langeback A; Bacanu S; Bergh J; Nordlund P
Editorial comment: DIABETES. 2014;63(12):e22-e23
Response to Comment on Sato et al. Improving type 2 diabetes through a distinct adrenergic signaling pathway involving mTORC2 that mediates glucose uptake in skeletal muscle. Diabetes 2014;63:4115-4129.
Sato M; Dehvari N; Oberg AI; Summers RJ; Hutchinson DS; Bengtsson T

Anställningar

Forskningsspecialist, Kvinnors och barns hälsa, Karolinska Institutet, 2022-

Examina och utbildning

PhD, Fysiology, Beta-adrenergic signalling and novel effects in skeletal muscle, Wenner-Gren Institut, Stockholms Universitet, 2013

Om mig

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI